These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Investigating the correlation between COVID-19 and the progression of chronic liver disease. Philips CA; Madhu D; Augustine P Expert Rev Gastroenterol Hepatol; 2023; 17(6):603-613. PubMed ID: 37086388 [TBL] [Abstract][Full Text] [Related]
5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection and liver involvement. Luo M; Ballester MP; Soffientini U; Jalan R; Mehta G Hepatol Int; 2022 Aug; 16(4):755-774. PubMed ID: 35767172 [TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated liver injury: from bedside to bench. Li D; Ding X; Xie M; Tian D; Xia L J Gastroenterol; 2021 Mar; 56(3):218-230. PubMed ID: 33527211 [TBL] [Abstract][Full Text] [Related]
8. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502 [TBL] [Abstract][Full Text] [Related]
9. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Xu Y; Yang X; Bian H; Xia M Lipids Health Dis; 2021 Oct; 20(1):126. PubMed ID: 34602072 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiological mechanisms of liver injury in COVID-19. Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346 [TBL] [Abstract][Full Text] [Related]
11. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury. Akkiz H Viruses; 2023 May; 15(6):. PubMed ID: 37376587 [TBL] [Abstract][Full Text] [Related]
12. Liver injury in severe COVID-19 infection: current insights and challenges. Ali N; Hossain K Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):879-884. PubMed ID: 32649840 [TBL] [Abstract][Full Text] [Related]
13. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature. Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691 [TBL] [Abstract][Full Text] [Related]
15. Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment. Qi RB; Wu ZH World J Virol; 2023 Jan; 12(1):22-29. PubMed ID: 36743657 [TBL] [Abstract][Full Text] [Related]
16. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship. D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501 [TBL] [Abstract][Full Text] [Related]
17. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471 [TBL] [Abstract][Full Text] [Related]
18. Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19. Jacobs AK; Morley SD; Samuel K; Morgan K; Boswell L; Kendall TJ; Dorward DA; Fallowfield JA; Hayes PC; Plevris JN World J Gastroenterol; 2024 Aug; 30(31):3705-3716. PubMed ID: 39192998 [TBL] [Abstract][Full Text] [Related]
19. Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation. Alqahtani SA; Aljumah AA; Hashim A; Alenazi TH; AlJawad M; Al Hamoudi WK; Alghamdi MY Ann Saudi Med; 2020; 40(4):273-280. PubMed ID: 32564624 [TBL] [Abstract][Full Text] [Related]
20. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications. Rodriguez-Espada A; Salgado-de la Mora M; Rodriguez-Paniagua BM; Limon-de la Rosa N; Martinez-Gutierrez MI; Pastrana-Brandes S; Navarro-Alvarez N World J Gastroenterol; 2024 Jun; 30(22):2866-2880. PubMed ID: 38947288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]